Wolfgang Barth
Keine laufenden Positionen mehr
Ursprung des Netzwerks ersten Grades von Wolfgang Barth
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
Avontec GmbH
Avontec GmbH Pharmaceuticals: MajorHealth Technology Avontec is a Phase 2 biopharmaceutical company focused on the development and commercialization of novel therapeutic treatments for inflammatory disease. Its clinical development programs include product candidates for multiple potential inflammatory indications. The two most advanced, AVT-01 in asthma and AVT-02 in psoriasis, have successfully advanced into Phase 2a clinical trials that the firm expects to be completed until the first half of 2008. In addition, there are several candidates in the pipeline based on Avontec's core decoy technology. Avontec operates based on a lean business model with a seasoned management team experienced in clinical development.
2
| Extinct | Pharmaceuticals: Major | 2 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Wolfgang Barth
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
Eberhard Karls Universität Tübingen | College/University | Doctorate Degree | |
Johann Wolfgang Goethe-Universität Frankfurt am Main | College/University | Masters Business Admin | |
Portus Corporate Finance | Corporate Officer/Principal |
Statistik
International
Deutschland | 6 |
Sektoral
Consumer Services | 3 |
Health Technology | 3 |
Operativ
Chief Tech/Sci/R&D Officer | 2 |
Director of Finance/CFO | 2 |
Doctorate Degree | 1 |
Masters Business Admin | 1 |
Corporate Officer/Principal | 1 |
Am stärksten vernetzte Beziehungen
Insiders | |
---|---|
Thomas Fink | 4 |
Stefan W. Henning | 3 |
- Börse
- Insiders
- Wolfgang Barth
- Unternehmensverbindungen